Cargando…
Construction and evaluation of detachable bone-targeting MOF carriers for the delivery of proteasome inhibitors
Tumor bone metastasis is an important cause of tumor recurrence and death. Although bone-targeting nanoparticles decorated with targeting ligands have shown good affinity for bone tissues with the properties of adhesion to the bone matrix, it is not easy to detach from the surface of the bone matrix...
Autores principales: | Yang, Hongbing, Yu, Zhenyan, Ji, Shuaishuai, Yan, Jie, Han, Lei, Liu, Yang, Wang, Yanjuan, Niu, Yimin, Huo, Qiang, Xu, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109260/ https://www.ncbi.nlm.nih.gov/pubmed/35702207 http://dx.doi.org/10.1039/d2ra00051b |
Ejemplares similares
-
A MOF-based carrier for in situ dopamine delivery
por: Pinna, Alessandra, et al.
Publicado: (2018) -
The mitochondrial pyruvate carrier complex potentiates the efficacy of proteasome inhibitors in multiple myeloma
por: Findlay, Steven, et al.
Publicado: (2023) -
DETACHMENT OF BACTERIOPHAGE FROM ITS CARRIER PARTICLES
por: Hetler, D. M., et al.
Publicado: (1931) -
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors
por: Nakaue, Emiko, et al.
Publicado: (2023) -
Construction of Novel Nanocomposites (Cu-MOF/GOD@HA) for Chemodynamic Therapy
por: Hao, Ya-Nan, et al.
Publicado: (2021)